Insights into Halogen-Induced Changes in 4-Anilinoquinazoline EGFR Inhibitors: A Computational Spectroscopic Study

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Biochemistry

Background:

• Epidermal Growth Factor Receptor (EGFR) is a key target in cancer therapy.
• 4-anilinoquinazoline derivatives are potent EGFR inhibitors.
• Halogen substitution impacts EGFR inhibitor potency, but mechanisms are unclear.

Purpose of the Study:

• Investigate the influence of halogen substitution (H, F, Cl, Br, I) on the structure, properties, and spectroscopy of 4-anilinoquinazoline EGFR inhibitors.
• Elucidate the relationship between halogen substitution, molecular properties, and tyrosine kinase inhibitor (TKI) potency.

Main Methods:

• Time-Dependent Density Functional Theory (TD-DFT) with B3LYP functional.
• Analysis of electronic properties (dipole moment, spatial extent).
• UV-visible spectral analysis and correlation with experimental potency (IC50 values).
• Conformational analysis and comparison with crystal structures.

Main Results:

• Halogen substitution alters electronic properties and dipole moments, affecting EGFR binding.
• Potency correlates with shorter UV-visible absorption wavelengths (blue shifts).
• More potent inhibitors (TKI-Cl, TKI-Br) show increased flexibility and higher dipole moments.
• Optimal drug conformation may not be the global minimum energy structure.

Conclusions:

• Halogen substitution significantly modulates electronic and spectral properties of EGFR inhibitors.
• Dipole moment and spectral shifts serve as reliable indicators of TKI potency.
• Molecular flexibility and specific low-lying conformers are crucial for high drug efficacy.
• Optical reporting offers a method to probe drug potency and conformational dynamics.